Inspire
Get Full AccessDescription
- Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire's goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. The most advanced compounds in Inspire's clinical pipeline are denufosol tetrasodium for cystic fibrosis and PROLACRIA(TM) (diquafosol tetrasodium ophthalmic solution) 2% for dry eye, which are both in Phase 3 development, and AZASITE(R) (azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT(R) (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye.
-
Headquarters:200 State St , Boston, Massachusetts, United States
More -
Phone Number: +1 617-478-4646
-
Website: https://www.inspirepharm.com
-
Employees:252
-
Revenue:$50 - 100M
-
Legal Name:Inspire
-
Inspire's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Inspire
-
Where are Inspire's Headquarters?
Inspire's Headquarters are in 200 State St ,Boston,Massachusetts,United States
-
What is Inspire's phone number?
Inspire's phone number is +1 617-478-4646
-
What is Inspire's official website?
Inspire's official website is https://www.inspirepharm.com
-
What is Inspire's Revenue?
Inspire's revenue is $50 - 100M
-
What is Inspire's NAICS code?
Inspire's NAICS code is 325412
-
How many employees are working in Inspire
Inspire has 252 employees
-
What is Inspire's Industry?
Inspire is in the industry of Pharmaceuticals
-
Who is Inspire's CEO?
Inspire's CEO is Michael Buchanan

